Back to 
BALYASNY ASSET MANAGEMENT L.P.
BALYASNY ASSET MANAGEMENT L.P.
NRXP1 quarters
Position history for BALYASNY ASSET MANAGEMENT L.P.'s holdings in NRX PHARMACEUTICALS INC
Yes. Balyasny Asset Management holds 893,864 shares of NRXP (NRX Pharmaceuticals), worth $3.7M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$3.7M
Current Shares
893,864
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of NRXP: VANGUARD CAPITAL MANAGEMENT LLC, AMERIPRISE FINANCIAL INC, CITADEL ADVISORS LLC, VANGUARD GROUP INC